Castleman's disease CT

Jump to navigation Jump to search

Castleman's disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Castleman's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Castleman's disease CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Castleman's disease CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Castleman's disease CT

CDC on Castleman's disease CT

Castleman's disease CT in the news

Blogs on Castleman's disease CT

Directions to Hospitals Treating Castleman's disease

Risk calculators and risk factors for Castleman's disease CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

CT Scan

  • To detect the enlarged lymph nodes in the chest, neck, abdomen, groin.
  • Enlargement of liver and spleen can also be detected.
  • Findings include:
    • Contrast enhancement
    • Homogenous
(A)Castleman's disease Preoperative CT scan of the abdomen showing a highly vascularized retroperitoneal tumor measuring 10 × 9.2 cm with intratumor calcifications. Right ureter dilatation (grade II), (coronal multiplanar reformation, MPR) (B) The same tumor in axial orientation. No other tumor localization in the abdomen nor enlarged lymph nodes were detected.

References

de:Morbus Castleman

Template:WS